Stock Market Reviews

MED (Medifast, Inc.) News

Get the latest news, insights, and market updates on MED (Medifast, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Medifast Announces Planned Leadership Transition
  BALTIMORE, January 05, 2026--Medifast, Inc. (NYSE: MED) today announced a planned leadership transition designed to provide continuity and stability as the company continues its evolution toward metabolic health.
  Jan 5, 2026 - $MED
• Medifast New Product Line Planned: Can Innovation Reignite Demand?
  MED plans a new product line rooted in metabolic synchronization science, upgrading its core offerings as it shifts beyond weight loss.
  Dec 30, 2025 - $MED
• Medifast's Third-Quarter Revenue Fell 36%: Is Stabilization Near?
  MED witnesses revenue plunge as its coach base shrank, but restructuring and productivity initiatives aim to stabilize results by late 2025.
  Dec 24, 2025 - $MED
• Hims & Hers Expands Subscription-Led Care as Platform Engagement Grows
  HIMS deepens its subscription-led model with new care verticals, diagnostics and global expansion to boost retention.
  Dec 23, 2025 - $MED
• 1 Consumer Stock to Target This Week and 2 We Question
  Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. But they’re also double-edged swords as they often lag in booming conditions, and this pattern has persisted recently. Over the past six months, the industry has recorded a loss of 5.8%, a far cry from the S&P 500’s 12.7% ascent.
  Dec 22, 2025 - $MED
• Can Medifast Overcome GLP-1 Pressure With Its Growth Strategy?
  MED targets long-term metabolic health with programs that preserve muscle and support lasting wellness amid GLP-1 adoption.
  Dec 18, 2025 - $MED
• Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks
  As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including Medifast (NYSE:MED) and its peers.
  Dec 18, 2025 - $MED
• OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing
  BALTIMORE, December 09, 2025--OPTAVIA, the science-backed, coach-guided lifestyle system, announced a new report "Metabolic Health in America: Awareness, Attitudes and Action." The report includes findings based on an online survey conducted by OPTAVIA with KRC Research among a nationally representative group of U.S. adults ages 18–75, recruited to match U.S. Census demographics*. The data highlights a pressing concern: 80% of American adults lack understanding of metabolic health, yet many are
  Dec 9, 2025 - $MED
• Why Medifast (MED) Stock Is Up Today
  Shares of wellness company Medifast (NYSE:MED) jumped 3.6% in the afternoon session after reports highlighted a consensus analyst price target suggesting a potential upside of more than 51%. A survey of recent analyst ratings showed a consensus target price for Medifast at $16.50. This price level implied a potential gain of 51.31% for the stock from its trading price at the time of the report. The bullish outlook appeared to have resonated with investors.
  Dec 8, 2025 - $MED
• Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves
  TEM expands its clinical AI reach through regulatory wins, a new oncology partnership and a major digital-pathology acquisition.
  Dec 5, 2025 - $MED